Psychosocial outcomes in the Yorkshire Kidney Screening Trial: moving the needle toward targeted screening for renal cell carcinoma

Renal cell carcinoma (RCC) has been recognised as a European healthcare issue. In the context of epidemiology and public health, screening refers to the practice of investigating apparently healthy individuals to detect unrecognised disease or early disease stages, aiming to prevent or delay the onset of disease, slow its progression, and reduce (premature) death. Despite screening and early detection being key priorities for clinicians and patients, neither population nor opportunistic screening is currently recommended for RCC.